시장보고서
상품코드
2060255

수의용 부형제 시장 분석 및 예측 : 유형, 제품 유형, 기술, 용도, 제형, 재료 유형, 제조 공정, 최종 사용자, 기능(-2035년)

Veterinary Excipients Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Form, Material Type, Process, End User, Functionality

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 7,376,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 8,929,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 10,482,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 수의용 부형제 시장은 2025년 13억 달러에서 2035년까지 19억 달러로 성장하여 CAGR은 4.1%를 나타낼 것으로 예측됩니다. 수의용 부형제 시장은 적정 수준의 통합 구조를 특징으로 하며, 시장 점유율의 약 30%를 차지하는 결합제 및 충전제가 주요 부문이고, 그 다음으로 방부제가 25%, 용매가 20%를 차지하고 있습니다. 주요 용도로는 경구제, 주사제 및 외용제가 있으며, 그중에서도 경구제가 가장 두드러집니다. 시장 규모는 일반적으로 톤 단위로 측정되며, 수의용 의약품 및 반려동물 관리 산업의 성장에 힘입어 안정적인 수요가 예상됩니다.

수의용 부형제 시장에서 ‘유형’ 부문은 결합제, 충전제, 보존제 등 첨가제의 화학적 성질이나 기능에 따라 분류하기 때문에 매우 중요합니다. 충전제는 수의용 제제의 부피 증가와 안정성을 높이기 위해 널리 사용되고 있어, 이 부문을 주도하고 있습니다. 수요는 주로 제약 업계에서 효과적인 약물 전달 시스템에 대한 필요성에 의해 주도되고 있습니다. 성장 동향을 살펴보면, 약제의 효능과 환자의 복약 순응도를 높일 수 있는 다기능 첨가제에 대한 수요가 증가하고 있습니다.

‘용도’ 부문에서는 경구용, 외용제, 주사제 등의 제형을 포함하여 수의학 분야에서 첨가제의 다양한 용도에 초점을 맞추었습니다. 경구 제제는 투여의 용이성과 반려동물 주인의 높은 복약 순응도에 힘입어 시장을 주도하고 있습니다. 반려동물의 만성 질환 증가와 축산업의 확대가 수요를 끌어올리는 주요 요인이 되고 있습니다. 특히, 경구 제제에서 유효 성분의 생체 이용률을 높이는 첨가제 개발이 활발히 진행되고 있는 추세입니다.

지역별 개요

북미는 확립된 동물 건강 관리 인프라와 수의약품 제조업체의 강력한 입지 덕분에 수의용 부형제 시장을 독점하고 있습니다. 반려동물 돌봄에 드는 높은 비용, 반려동물의 ‘인간화’ 추세, 그리고 첨단 수의학의 보급이 고품질 부형제에 대한 수요를 뒷받침하는 주요 요인으로 작용하고 있습니다. 또한, 이 지역에는 의약품의 안전성과 제제의 품질을 중시하는 엄격한 규제 체계가 마련되어 있어, 이로 인해 특수 첨가제의 사용이 촉진되고 있습니다. 또한, 제약사와 원료 공급업체 간의 강력한 연구개발 역량과 협력을 통해 혁신이 더욱 촉진되고, 안정적인 수요가 확보됨과 동시에 시장 내 해당 지역의 주도적 입지가 강화되고 있습니다.

아시아태평양은 동물 보건 산업의 급속한 확대와 가축 및 반려동물 관리에 대한 관심 증가에 힘입어, 수의용 부형제 시장에서 가장 빠르게 성장하고 있는 지역입니다. 경제 발전과 도시화는 반려동물 사육 마릿수 증가와 수의학 서비스의 향상에 기여하고 있으며, 그 결과 수의용 의약품 및 관련 첨가제에 대한 수요가 증가하고 있습니다. 또한, 이 지역은 막대한 가축 사육 규모와 안전하고 효과적인 수의용 헬스케어 제품에 대한 수요 증가로 인해 큰 성장 잠재력을 지니고 있습니다. 또한, 특히 인도나 중국 등 국가들의 제조 역량 향상과 수의학 연구 개발에 대한 투자 확대가 지역 시장의 성장을 가속화하고 있습니다.

주요 동향 및 촉진요인

동물 건강 관리 및 첨단 수의용 의약품에 대한 수요 증가:

반려동물 사육 마릿수 증가와 가축 사육 규모 확장에 힘입어 동물 건강에 대한 관심이 높아지고 있는 것이 수의용 부형제 시장의 주요 성장 동력이 되고 있습니다. 수의학 분야 지출 증가와 효과적인 제제에 대한 수요 증가로 인해, 의약품에 사용되는 고품질 첨가제에 대한 수요가 높아지고 있습니다. 또한, 수의약품의 발전과 제형의 복잡화에 따라 안정성, 생체이용률 및 전달성을 향상시키기 위한 특수 첨가제가 필요해지고 있습니다. 전 세계적으로 동물 복지 및 질병 관리에 대한 인식이 지속적으로 높아짐에 따라, 안전하고 효율적인 수의약품에 대한 수요가 증가하고 있으며, 이에 따라 시장에서 첨단 첨가제의 도입이 가속화되고 있습니다.

바이오의약품 및 천연 유래 첨가제의 사용 확대:

바이오의약품, 백신 및 천연 성분을 기반으로 한 제제로의 전환이 진행되고 있는 것은 수의용 부형제 시장에 큰 기회를 제공합니다. 첨단 약물 전달 시스템을 지원하고 안정성을 높일 수 있는 첨가제에 대한 수요가 증가하고 있습니다. 또한, 천연 및 지속 가능한 성분에 대한 소비자의 선호도가 식물 유래 첨가제 개발을 촉진하고 있습니다. 신흥 시장에서 수의학의 확대와 동물 보건 조사에 대한 투자 증가는 새로운 성장의 길을 열어주고 있습니다. 이러한 동향에 힘입어 제조업체들은 제품 포트폴리오를 혁신하고 확장할 수 있게 되었으며, 장기적인 시장 확대를 위한 강력한 기회가 창출되고 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 당사에 대해

JHS 26.06.19

The global Veterinary Excipients Market is projected to grow from $1.3 billion in 2025 to $1.9 billion by 2035, at a compound annual growth rate (CAGR) of 4.1%. The Veterinary Excipients Market is characterized by a moderately consolidated structure, with the top segments being binders and fillers, accounting for approximately 30% of the market share, followed by preservatives at 25%, and solvents at 20%. Key applications include oral formulations, injectables, and topical applications, with oral formulations being the most prominent. The market volume is typically measured in metric tons, with a steady demand driven by the growth in veterinary pharmaceuticals and pet care industries.

In the Veterinary Excipients Market, the 'Type' segment is crucial as it categorizes excipients based on their chemical nature and functionality, such as binders, fillers, and preservatives. Fillers dominate this segment due to their widespread use in enhancing the bulk and stability of veterinary formulations. The demand is primarily driven by the pharmaceutical industry's need for effective drug delivery systems. Growth trends indicate a rising preference for multifunctional excipients that can improve drug efficacy and patient compliance.

Market Segmentation
TypeBinders, Diluents, Disintegrants, Lubricants, Preservatives, Solvents, Coating Agents, Flavoring Agents, Coloring Agents, Others
ProductTablets, Capsules, Injectables, Topicals, Powders, Liquids, Gels, Ointments, Suppositories, Others
TechnologyMicroencapsulation, Nanotechnology, Controlled Release, Others
ApplicationOral, Parenteral, Topical, Inhalation, Ophthalmic, Nasal, Rectal, Transdermal, Buccal, Others
FormSolid, Liquid, Semi-Solid, Others
Material TypeSynthetic, Natural, Semi-Synthetic, Others
ProcessManufacturing, Formulation, Packaging, Others
End UserVeterinary Clinics, Animal Research Institutes, Pharmaceutical Companies, Contract Manufacturing Organizations, Others
FunctionalityStabilizers, Emulsifiers, Suspending Agents, Thickening Agents, Others

The 'Application' segment highlights the diverse uses of excipients in veterinary medicine, including oral, topical, and injectable formulations. Oral applications lead the market, driven by the ease of administration and high compliance rates among pet owners. The increasing prevalence of chronic diseases in companion animals and the expansion of livestock farming are key factors boosting demand. Notably, there is a growing trend towards developing excipients that enhance the bioavailability of active ingredients in oral formulations.

Geographical Overview

North America dominates the veterinary excipients market due to its well-established animal healthcare infrastructure and strong presence of veterinary pharmaceutical manufacturers. High spending on companion animal care, increasing pet humanization, and widespread adoption of advanced veterinary treatments are key factors supporting demand for high-quality excipients. The region also benefits from stringent regulatory frameworks that emphasize drug safety and formulation quality, encouraging the use of specialized excipients. In addition, strong research and development capabilities and collaboration between pharmaceutical companies and ingredient suppliers further enhance innovation, ensuring consistent demand and reinforcing the region's leading position in the market.

Asia Pacific is the fastest-growing region in the veterinary excipients market, driven by rapid expansion of the animal health industry and increasing focus on livestock and companion animal care. Economic development and urbanization are contributing to higher pet ownership and improved veterinary services, which in turn increase demand for veterinary medicines and associated excipients. The region also offers strong growth opportunities due to large livestock populations and rising need for safe and effective animal healthcare products. Additionally, growing manufacturing capabilities, particularly in countries like India and China, along with increasing investments in veterinary research, are accelerating regional market expansion.

Key Trends and Drivers

Increasing Demand for Animal Healthcare and Advanced Veterinary Medicines:

The growing focus on animal health, driven by rising pet ownership and expanding livestock populations, is a key driver for the veterinary excipients market. Increasing expenditure on veterinary care and the need for effective drug formulations are boosting demand for high-quality excipients used in medicines. Additionally, advancements in veterinary pharmaceuticals and the growing complexity of formulations require specialized excipients for improved stability, bioavailability, and delivery. As awareness around animal welfare and disease management continues to rise globally, the demand for safe and efficient veterinary drugs is increasing, thereby accelerating the adoption of advanced excipients in the market.

Growing Adoption of Biologics and Natural Excipients:

The increasing shift toward biologics, vaccines, and natural ingredient-based formulations presents significant opportunities in the veterinary excipients market. With the rise of advanced therapies, there is growing demand for excipients that can support complex drug delivery systems and enhance stability. Additionally, consumer preference for natural and sustainable ingredients is encouraging the development of plant-based excipients. Expanding veterinary healthcare in emerging markets and increasing investments in animal health research are further opening new growth avenues. These trends are enabling manufacturers to innovate and expand their product portfolios, creating strong opportunities for long-term market expansion.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by Form
  • 2.5 Key Market Highlights by Material Type
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Functionality
  • 2.8 Key Market Highlights by Technology
  • 2.9 Key Market Highlights by Process

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Binders
    • 4.1.2 Diluents
    • 4.1.3 Disintegrants
    • 4.1.4 Lubricants
    • 4.1.5 Preservatives
    • 4.1.6 Solvents
    • 4.1.7 Coating Agents
    • 4.1.8 Flavoring Agents
    • 4.1.9 Coloring Agents
    • 4.1.10 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Tablets
    • 4.2.2 Capsules
    • 4.2.3 Injectables
    • 4.2.4 Topicals
    • 4.2.5 Powders
    • 4.2.6 Liquids
    • 4.2.7 Gels
    • 4.2.8 Ointments
    • 4.2.9 Suppositories
    • 4.2.10 Others
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Oral
    • 4.3.2 Parenteral
    • 4.3.3 Topical
    • 4.3.4 Inhalation
    • 4.3.5 Ophthalmic
    • 4.3.6 Nasal
    • 4.3.7 Rectal
    • 4.3.8 Transdermal
    • 4.3.9 Buccal
    • 4.3.10 Others
  • 4.4 Market Size & Forecast by Form (2020-2035)
    • 4.4.1 Solid
    • 4.4.2 Liquid
    • 4.4.3 Semi-Solid
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Material Type (2020-2035)
    • 4.5.1 Synthetic
    • 4.5.2 Natural
    • 4.5.3 Semi-Synthetic
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Veterinary Clinics
    • 4.6.2 Animal Research Institutes
    • 4.6.3 Pharmaceutical Companies
    • 4.6.4 Contract Manufacturing Organizations
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Stabilizers
    • 4.7.2 Emulsifiers
    • 4.7.3 Suspending Agents
    • 4.7.4 Thickening Agents
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Technology (2020-2035)
    • 4.8.1 Microencapsulation
    • 4.8.2 Nanotechnology
    • 4.8.3 Controlled Release
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Manufacturing
    • 4.9.2 Formulation
    • 4.9.3 Packaging
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 Form
      • 5.2.1.5 Material Type
      • 5.2.1.6 End User
      • 5.2.1.7 Functionality
      • 5.2.1.8 Technology
      • 5.2.1.9 Process
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 Form
      • 5.2.2.5 Material Type
      • 5.2.2.6 End User
      • 5.2.2.7 Functionality
      • 5.2.2.8 Technology
      • 5.2.2.9 Process
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 Form
      • 5.2.3.5 Material Type
      • 5.2.3.6 End User
      • 5.2.3.7 Functionality
      • 5.2.3.8 Technology
      • 5.2.3.9 Process
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 Form
      • 5.3.1.5 Material Type
      • 5.3.1.6 End User
      • 5.3.1.7 Functionality
      • 5.3.1.8 Technology
      • 5.3.1.9 Process
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 Form
      • 5.3.2.5 Material Type
      • 5.3.2.6 End User
      • 5.3.2.7 Functionality
      • 5.3.2.8 Technology
      • 5.3.2.9 Process
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 Form
      • 5.3.3.5 Material Type
      • 5.3.3.6 End User
      • 5.3.3.7 Functionality
      • 5.3.3.8 Technology
      • 5.3.3.9 Process
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 Form
      • 5.4.1.5 Material Type
      • 5.4.1.6 End User
      • 5.4.1.7 Functionality
      • 5.4.1.8 Technology
      • 5.4.1.9 Process
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 Form
      • 5.4.2.5 Material Type
      • 5.4.2.6 End User
      • 5.4.2.7 Functionality
      • 5.4.2.8 Technology
      • 5.4.2.9 Process
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 Form
      • 5.4.3.5 Material Type
      • 5.4.3.6 End User
      • 5.4.3.7 Functionality
      • 5.4.3.8 Technology
      • 5.4.3.9 Process
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 Form
      • 5.4.4.5 Material Type
      • 5.4.4.6 End User
      • 5.4.4.7 Functionality
      • 5.4.4.8 Technology
      • 5.4.4.9 Process
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 Form
      • 5.4.5.5 Material Type
      • 5.4.5.6 End User
      • 5.4.5.7 Functionality
      • 5.4.5.8 Technology
      • 5.4.5.9 Process
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 Form
      • 5.4.6.5 Material Type
      • 5.4.6.6 End User
      • 5.4.6.7 Functionality
      • 5.4.6.8 Technology
      • 5.4.6.9 Process
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 Form
      • 5.4.7.5 Material Type
      • 5.4.7.6 End User
      • 5.4.7.7 Functionality
      • 5.4.7.8 Technology
      • 5.4.7.9 Process
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 Form
      • 5.5.1.5 Material Type
      • 5.5.1.6 End User
      • 5.5.1.7 Functionality
      • 5.5.1.8 Technology
      • 5.5.1.9 Process
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 Form
      • 5.5.2.5 Material Type
      • 5.5.2.6 End User
      • 5.5.2.7 Functionality
      • 5.5.2.8 Technology
      • 5.5.2.9 Process
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 Form
      • 5.5.3.5 Material Type
      • 5.5.3.6 End User
      • 5.5.3.7 Functionality
      • 5.5.3.8 Technology
      • 5.5.3.9 Process
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 Form
      • 5.5.4.5 Material Type
      • 5.5.4.6 End User
      • 5.5.4.7 Functionality
      • 5.5.4.8 Technology
      • 5.5.4.9 Process
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 Form
      • 5.5.5.5 Material Type
      • 5.5.5.6 End User
      • 5.5.5.7 Functionality
      • 5.5.5.8 Technology
      • 5.5.5.9 Process
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 Form
      • 5.5.6.5 Material Type
      • 5.5.6.6 End User
      • 5.5.6.7 Functionality
      • 5.5.6.8 Technology
      • 5.5.6.9 Process
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 Form
      • 5.6.1.5 Material Type
      • 5.6.1.6 End User
      • 5.6.1.7 Functionality
      • 5.6.1.8 Technology
      • 5.6.1.9 Process
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 Form
      • 5.6.2.5 Material Type
      • 5.6.2.6 End User
      • 5.6.2.7 Functionality
      • 5.6.2.8 Technology
      • 5.6.2.9 Process
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 Form
      • 5.6.3.5 Material Type
      • 5.6.3.6 End User
      • 5.6.3.7 Functionality
      • 5.6.3.8 Technology
      • 5.6.3.9 Process
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 Form
      • 5.6.4.5 Material Type
      • 5.6.4.6 End User
      • 5.6.4.7 Functionality
      • 5.6.4.8 Technology
      • 5.6.4.9 Process
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 Form
      • 5.6.5.5 Material Type
      • 5.6.5.6 End User
      • 5.6.5.7 Functionality
      • 5.6.5.8 Technology
      • 5.6.5.9 Process

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 BASF
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Dow Chemical Company
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Evonik Industries
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Ashland Global Holdings
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Clariant
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Croda International
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Archer Daniels Midland Company
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Roquette Freres
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 FMC Corporation
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Kerry Group
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 JRS Pharma
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Merck KGaA
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Colorcon
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lubrizol Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Ingredion Incorporated
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Eastman Chemical Company
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Gattefosse
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 MEGGLE Group
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 DFE Pharma
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 SEPPIC
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기